ATE301713T1 - Plazentaprotein 13 - Google Patents

Plazentaprotein 13

Info

Publication number
ATE301713T1
ATE301713T1 AT99901094T AT99901094T ATE301713T1 AT E301713 T1 ATE301713 T1 AT E301713T1 AT 99901094 T AT99901094 T AT 99901094T AT 99901094 T AT99901094 T AT 99901094T AT E301713 T1 ATE301713 T1 AT E301713T1
Authority
AT
Austria
Prior art keywords
placenta protein
placenta
protein
Prior art date
Application number
AT99901094T
Other languages
English (en)
Inventor
Arie Admon
Yoav Paltieli
Ronit Slotky
Silvia Mandel
Original Assignee
Diagnostic Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagnostic Technologies Ltd filed Critical Diagnostic Technologies Ltd
Application granted granted Critical
Publication of ATE301713T1 publication Critical patent/ATE301713T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4715Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/97Test strip or test slide
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/807Apparatus included in process claim, e.g. physical support structures
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/815Test for named compound or class of compounds
    • Y10S436/817Steroids or hormones
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/822Identified hapten
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/824Immunological separation techniques

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Biochemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gynecology & Obstetrics (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT99901094T 1998-01-29 1999-01-21 Plazentaprotein 13 ATE301713T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL12309898A IL123098A0 (en) 1998-01-29 1998-01-29 Placental protein 13
PCT/IL1999/000036 WO1999038970A1 (en) 1998-01-29 1999-01-21 Placental protein 13

Publications (1)

Publication Number Publication Date
ATE301713T1 true ATE301713T1 (de) 2005-08-15

Family

ID=11071151

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99901094T ATE301713T1 (de) 1998-01-29 1999-01-21 Plazentaprotein 13

Country Status (13)

Country Link
US (2) US6548306B1 (de)
EP (1) EP1051487B1 (de)
JP (1) JP2002516658A (de)
AR (1) AR018045A1 (de)
AT (1) ATE301713T1 (de)
AU (1) AU2071799A (de)
CA (1) CA2319699C (de)
DE (1) DE69926606T2 (de)
DK (1) DK1051487T3 (de)
ES (1) ES2246563T3 (de)
IL (2) IL123098A0 (de)
WO (1) WO1999038970A1 (de)
ZA (1) ZA99677B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL123098A0 (en) * 1998-01-29 1998-09-24 Diagnostic Technologies Ltd Placental protein 13
IL129273A (en) * 1999-03-30 2003-10-31 Diagnostic Technologies Ltd Monoclonal antibody to placental protein 13 and immunoassay and kit using said antibody
WO2001049163A1 (en) * 2000-01-03 2001-07-12 Tr Associates, L.L.C. Pp14 fusion proteins and methods for making and using the same
WO2004021012A2 (en) * 2002-08-29 2004-03-11 Diagnostic Technologies Ltd. Method of diagnosis of pregnancy-related complications
US7776557B2 (en) 2006-01-30 2010-08-17 Diagnostic Technologies Ltd. Method for monitoring tocolytic treatment
EP1979749A1 (de) * 2006-02-02 2008-10-15 Diagnostic Technologies Ltd. Verfahren zur bestimmung der wirksamkeit einer behandlung für präeklampsie
JP2010517525A (ja) * 2007-02-01 2010-05-27 ダイアグノスティク テクノロジーズ リミテッド 子癇前症リスクの判定方法
CN112341533A (zh) * 2020-11-20 2021-02-09 东北师范大学 无标签人半乳糖凝集素13及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
DE3230996A1 (de) * 1982-08-20 1984-02-23 Behringwerke Ag, 3550 Marburg Neues protein (pp(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)3(pfeil abwaerts)), verfahren zu seiner anreicherung und gewinnung sowie seine verwendung
US5198366A (en) 1986-03-23 1993-03-30 Technion Research & Development Foundation Ltd. Method for the detection of pregnancy disorders
EP0283606B1 (de) * 1987-03-24 1992-07-15 Technion Research & Development Foundation Ltd. Verfahren zur Feststellung von Schwangerschaftsstörungen
IL123098A0 (en) * 1998-01-29 1998-09-24 Diagnostic Technologies Ltd Placental protein 13

Also Published As

Publication number Publication date
IL137497A0 (en) 2001-07-24
AR018045A1 (es) 2001-10-31
CA2319699A1 (en) 1999-08-05
JP2002516658A (ja) 2002-06-11
DK1051487T3 (da) 2005-11-14
DE69926606D1 (de) 2005-09-15
AU2071799A (en) 1999-08-16
IL123098A0 (en) 1998-09-24
ES2246563T3 (es) 2006-02-16
ZA99677B (en) 1999-09-02
CA2319699C (en) 2007-06-12
US6548306B1 (en) 2003-04-15
DE69926606T2 (de) 2006-06-08
EP1051487B1 (de) 2005-08-10
WO1999038970A1 (en) 1999-08-05
US20030092188A1 (en) 2003-05-15
EP1051487A1 (de) 2000-11-15
US7211405B2 (en) 2007-05-01

Similar Documents

Publication Publication Date Title
NO982097L (no) Peptider
NO982098D0 (no) Peptider
CY2006006I2 (el) Πρωτεϊνικα σκευασματα
ID24289A (id) Benzotiazol inhibitor-inhibitor protein terosin kinase
DE69920011D1 (de) Rekombinanter venezolanische-equine-pferdeenzephalitis-virusimpstoff
NO985294D0 (no) Kontrastmidler
NO996108D0 (no) 9-oksinerytromycinderivater
ID24669A (id) Turunan-turunan dolastatin 15
ATE260674T1 (de) Stabilisierte proteinzusammensetzung
DE59912684D1 (de) Folienförmige wirkstoffträger
ATE301713T1 (de) Plazentaprotein 13
ATE246494T1 (de) Brausezubereitungen
DE69925271D1 (de) Angiostatin-bindendes protein
NO20004167D0 (no) Kaspase-8 interagerende proteiner
DK0862850T3 (da) Mejetærsker
TR199701666A3 (tr) Sismanliga karsi proteinler
FI973822A0 (fi) Mekaniskt sjaelvrensande sil
DK1171470T3 (da) Antistoffer over for placentaprotein 13
NO20005551D0 (no) 2"-deoksyhygromycinderivater
DE69709700D1 (de) Kontrastmittel
NO996127D0 (no) 13-dihydro-3'-aziridino-antracykliner
FI960739A0 (fi) Sil
DK1088069T3 (da) Angiostatin-bindende protein
FR2778665B1 (fr) Polypeptide prax-1
FR2778536B3 (fr) Peigne ou similaire

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1051487

Country of ref document: EP

REN Ceased due to non-payment of the annual fee